Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Neurorehabilitation Device Market Forecast 2021-2028

Published by Inkwood Research Product code 980916
Published Content info 151 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Neurorehabilitation Device Market Forecast 2021-2028
Published: January 11, 2021 Content info: 151 Pages
Description

KEY FINDINGS

The Europe neurorehabilitation device market is anticipated to evolve with a CAGR of 15.02%, during the forecast period of 2021 to 2028. The rising geriatric population, the increasing incidence of strokes, newly developed neurorehabilitation facilities, and federal investments for researching neurodegenerative conditions, are among the main factors accredited to the region's market growth.

MARKET INSIGHTS

The Europe neurorehabilitation device market growth is assessed by analyzing Belgium, Italy, Poland, Germany, the United Kingdom, Russia, France, and the rest of Europe. As per the Alzheimer's and Dementia Resources, over 1 million people are presently living with dementia, in Italy. Likewise, nearly 44 million people have dementia, worldwide, thereby making the condition a global health crisis. Italy's national health plan, Servizio Sanitario Nazionale, provides hospital and medical advantages. The country's healthcare is deemed a right, with the national health plan designed to cater to all citizens, including Italy's legal residents from Canada and the United States, owing to the country's healthcare plan. The majority of the care is free or affordable, counting general physicians' consults, hospital visits, lab work, and medication.

In Poland, the number of people with dementia is relatively lower than the European Union's average of 1.55%. Also, according to statistics, the median age across the nation is over 38, and this figure is anticipated to increase to 51, over the upcoming decades. As the population continues to age, it is also declining, from 38 million in 2010, to 32 million, in 2050. As a result, the surging aging populace is projected to create an increase in Alzheimer's diseases recorded, across the country. Therefore, such factors are anticipated to fuel the neurorehabilitation device market growth during the forecast period.

COMPETITIVE INSIGHTS

Leading companies operating in the market include, Biometrics Ltd, Ectron Limited, Hocoma AG, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 17577

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GROWING ELDERLY POPULACE
    • 3.1.2. GROWING NEUROREHABILITATION WEARABLES AND ROBOTICS
    • 3.1.3. SIGNIFICANT RISE IN NEUROLOGICAL DISEASES
    • 3.1.4. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF TREATMENT
    • 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICALS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRANTS
    • 4.1.2. THREAT OF SUBSTITUTES
    • 4.1.3. BARGAINING POWER OF BUYER
    • 4.1.4. BARGAINING POWER OF SUPPLIER
    • 4.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON NEUROREHABILITATION DEVICE MARKET
  • 4.3. SUPPLY CHAIN ANALYSIS
  • 4.4. TIMELINE OF NEUROREHABILITATION DEVICE
  • 4.5. KEY BUYING CRITERIA
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE
  • 4.8. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. NEURO-ROBOTIC SYSTEM
  • 5.2. BRAIN COMPUTER INTERFACE
  • 5.3. WEARABLE DEVICE
  • 5.4. NON-INVASIVE STIMULATOR
  • 5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. STROKE
  • 6.2. CEREBRAL PALSY
  • 6.3. PARKINSON'S DISEASE
  • 6.4. MULTIPLE SCLEROSIS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. HOSPITAL/CLINIC
  • 7.2. RESEARCH INSTITUTE
  • 7.3. COGNITIVE CARE CENTER
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. GERMANY
      • 8.1.5.2. FRANCE
      • 8.1.5.3. UNITED KINGDOM
      • 8.1.5.4. ITALY
      • 8.1.5.5. RUSSIA
      • 8.1.5.6. BELGIUM
      • 8.1.5.7. POLAND
      • 8.1.5.8. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. BIOMETRICS LTD
    • 9.2.3. BIONIK LABORATORIES CORP
    • 9.2.4. BIOXTREME
    • 9.2.5. ECTRON LIMITED
    • 9.2.6. EKSO BIONICS HOLDINGS INC
    • 9.2.7. HELIUS MEDICAL TECHNOLOGIES
    • 9.2.8. HOCOMA AG
    • 9.2.9. KINESTICA
    • 9.2.10. KINOVA
    • 9.2.11. MEDTRONIC INC
    • 9.2.12. NEUROSTYLE PTE LTD
    • 9.2.13. TYROMOTION GMBH

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROREHABILITATION DEVICE
  • TABLE 2: EUROPE NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 3: EUROPE NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 4: EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 5: EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 6: EUROPE NEUROREHABILITATION DEVICE MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 7: EUROPE NEUROREHABILITATION DEVICE MARKET, BY END-USER, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 8: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN EUROPE NEUROREHABILITATION DEVICE MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: TIMELINE OF NEUROREHABILITATION DEVICE MARKET
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: EUROPE NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, IN 2020
  • FIGURE 7: EUROPE NEUROREHABILITATION DEVICE MARKET, BY NEURO-ROBOTIC SYSTEM, 2021-2028 ($ MILLION)
  • FIGURE 8: EUROPE NEUROREHABILITATION DEVICE MARKET, BY BRAIN COMPUTER INTERFACE, 2021-2028 ($ MILLION)
  • FIGURE 9: EUROPE NEUROREHABILITATION DEVICE MARKET, BY WEARABLE DEVICE, 2021-2028 ($ MILLION)
  • FIGURE 10: EUROPE NEUROREHABILITATION DEVICE MARKET, BY NON-INVASIVE STIMULATOR, 2021-2028 ($ MILLION)
  • FIGURE 11: EUROPE NEUROREHABILITATION DEVICE MARKET BY, OTHER PRODUCTS, 2021-2028 ($ MILLION)
  • FIGURE 12: EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, IN 2020
  • FIGURE 13: EUROPE NEUROREHABILITATION DEVICE MARKET, BY STROKE, 2021-2028 ($ MILLION)
  • FIGURE 14: EUROPE NEUROREHABILITATION DEVICE MARKET, BY CEREBRAL PALSY, 2021-2028 ($ MILLION)
  • FIGURE 15: EUROPE NEUROREHABILITATION DEVICE MARKET, BY PARKINSON'S DISEASE, 2021-2028 ($ MILLION)
  • FIGURE 16: EUROPE NEUROREHABILITATION DEVICE MARKET, BY MULTIPLE SCLEROSIS, 2021-2028 ($ MILLION)
  • FIGURE 17: EUROPE NEUROREHABILITATION DEVICE MARKET, BY OTHER APPLICATIONS, 2021-2028 ($ MILLION)
  • FIGURE 18: EUROPE NEUROREHABILITATION DEVICE MARKET, BY END-USER, IN 2020
  • FIGURE 19: EUROPE NEUROREHABILITATION DEVICE MARKET, BY HOSPITAL/CLINIC, 2021-2028 ($ MILLION)
  • FIGURE 20: EUROPE NEUROREHABILITATION DEVICE MARKET, BY RESEARCH INSTITUTE, 2021-2028 ($ MILLION)
  • FIGURE 21: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COGNITIVE CARE CENTER, 2021-2028 ($ MILLION)
  • FIGURE 22: EUROPE NEUROREHABILITATION DEVICE MARKET, BY OTHER END-USERS, 2021-2028 ($ MILLION)
  • FIGURE 23: EUROPE NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: GERMANY NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 25: FRANCE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 26: UNITED KINGDOM NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 27: ITALY NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: RUSSIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: BELGIUM NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: POLAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
Back to Top